Showing results (131-140 of 168) with videos related to

Sort By:
Pageof 17
Clinical Lymphoma, Myeloma & Leukemia|May 27, 2019
Diagnostic and Clinical Impact of Staging 18F-FDG PET/CT in Mantle-Cell Lymphoma: A Two-Center ExperienceDomenico Albano, Paola Ferro, Giovanni Bosio, et al.
European Journal of Endocrinology|June 15, 2018
Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelinesDomenico Albano, Francesco Bertagna, Mattia Bonacina, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 3, 2020
Incidental Findings Suggestive of COVID-19 in Asymptomatic Patients Undergoing Nuclear Medicine Procedures in a High-Prevalence RegionDomenico Albano, Francesco Bertagna, Mattia Bertoli, et al.
Nuclear Medicine Communications|August 7, 2009
Residual brain viability, evaluated by (99m)Tc-ECD SPECT, in patients with suspected brain death and with confounding clinical factorsFrancesco Bertagna, Ottorino Barozzi, Erinda Puta, et al.
Cardiovascular Drugs and Therapy|March 31, 2010
Role of beta-adrenergic receptor gene polymorphisms in the long-term effects of beta-blockade with carvedilol in patients with chronic heart failureMarco Metra, Loredana Covolo, Natalia Pezzali, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|September 1, 2018
Inter-reader variability of SPECT MPI readings in low- and middle-income countries: Results from the IAEA-MPI Audit Project (I-MAP)Maurizio Dondi, Carlo Rodella, Raffaele Giubbini, et al.
Nuclear Medicine Communications|December 5, 2015
The strange case of the [13N]NH3: validation of the production process for human useMassimo Statuto, Elisa Galli, Francesco Bertagna, et al.
Breast Care (Basel, Switzerland)|March 21, 2014
Peptide Receptor Radionuclide Therapy (PRRT) in a Patient Affected by Metastatic Breast Cancer with Neuroendocrine DifferentiationGiordano Savelli, Alberto Zaniboni, Francesco Bertagna, et al.
Pageof 17